Last reviewed · How we verify
Anemia in chronic kidney disease
Approved treatments
- Enaroy · Japan Tabacco
- Jesduvroq · GSK
Jesduvroq works by activating hypoxia-inducible factor prolyl hydroxylase inhibitors, which increases the production of erythropoietin, a hormone that stimulates red blood cell production. - Nandrolone Decanoate · Woodward Specl
- Silapo · Hospira UK Limited
- Mircera · Hoffman-La Roche
Mircera activates erythropoietin receptors, increasing red cell production in response to hypoxia. - Epogen · Johns Hopkins University
- Epogen · Amgen
Epogen works by binding to the erythropoietin receptor, triggering a cascade of signals that stimulate the production of red blood cells. - Procrit · University of Louisville
- Erythropoietin · Nanjing First Hospital, Nanjing Medical University
- Neorecormon · Roche Registration Limited
Neorecormon works by binding to the erythropoietin receptor, mimicking the action of natural erythropoietin to stimulate red blood cell production. - Evrenzo · Astellas Pharma Europe B.V.
- Epogen · Amgen
Epoetin alfa stimulates erythropoiesis by the same mechanism as endogenous erythropoietin. - Mircera · Samsung Medical Center
- Neorecormon · Centre Hospitalier Universitaire, Amiens
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anemia in chronic kidney disease patent landscape — cliff calendar, originator estates, attackable patents
- Anemia in chronic kidney disease treatment landscape brief
- Anemia in chronic kidney disease treatment updates RSS
Frequently asked questions about Anemia in chronic kidney disease
What drugs treat Anemia in chronic kidney disease?
Tracked treatments include Enaroy, Jesduvroq, Nandrolone Decanoate, Silapo, Mircera, Epogen, Procrit, Erythropoietin.
What is the treatment for Anemia in chronic kidney disease?
Standard treatment for Anemia in chronic kidney disease includes Enaroy, Jesduvroq, Nandrolone Decanoate, Silapo, Mircera. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Anemia in chronic kidney disease patent cliff · Anemia in chronic kidney disease CI report
- Treatment: Enaroy · Japan Tabacco
- Treatment: Jesduvroq · GSK
- Treatment: Nandrolone Decanoate · Woodward Specl
- Treatment: Silapo · Hospira UK Limited
- Treatment: Mircera · Hoffman-La Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing